302 related articles for article (PubMed ID: 27496094)
1. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
5. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
6. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
8. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
9. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
11. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
12. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
He XX; Tu SM; Lee MH; Yeung SJ
Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
15. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
16. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
17. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
18. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
[TBL] [Abstract][Full Text] [Related]
19. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.
Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH
J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173
[TBL] [Abstract][Full Text] [Related]
20. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
